dc.creatorIslan, Germán Abel
dc.creatorDurán, Marcela
dc.creatorCacicedo, Maximiliano Luis
dc.creatorNakazato, Gerson
dc.creatorKobayashi, Renata K. T.
dc.creatorMartinez, Diego S. T.
dc.creatorCastro, Guillermo Raúl
dc.creatorDurán, Nelson
dc.date2017-06
dc.date2020-07-13T17:34:37Z
dc.date.accessioned2023-07-14T19:51:35Z
dc.date.available2023-07-14T19:51:35Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/100518
dc.identifierhttps://ri.conicet.gov.ar/11336/49424
dc.identifierissn:0001-706X
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7436964
dc.descriptionThe study of neglected diseases has not received much attention, especially from public and private institutions over the last years, in terms of strong support for developing treatment for these diseases. Support in the form of substantial amounts of private and public investment is greatly needed in this area. Due to the lack of novel drugs for these diseases, nanobiotechnology has appeared as an important new breakthrough for the treatment of neglected diseases. Recently, very few reviews focusing on filiarasis, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, trypanosomiasis, and tuberculosis, and dengue virus have been published. New developments in nanocarriers have made promising advances in the treatment of several kinds of diseases with less toxicity, high efficacy and improved bioavailability of drugs with extended release and fewer applications. This review deals with the current status of nanobiotechnology in the treatment of neglected diseases and highlights how it provides key tools for exploring new perspectives in the treatment of a wide range of diseases.
dc.descriptionCentro de Investigación y Desarrollo en Fermentaciones Industriales
dc.formatapplication/pdf
dc.format16-42
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.subjectQuímica
dc.subjectLiposomes
dc.subjectNanobiotechnology
dc.subjectNanoemulsions
dc.subjectNanoparticles
dc.subjectNeglected diseases
dc.subjectSolid lipid nanoparticles
dc.titleNanopharmaceuticals as a solution to neglected diseases: is it possible?
dc.typeArticulo
dc.typePreprint


Este ítem pertenece a la siguiente institución